Profile data is unavailable for this security.
About the company
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. It develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.
- Revenue in EUR (TTM)684.60m
- Net income in EUR127.00m
- Incorporated2006
- Employees2.43k
- LocationBiotest AGLandsteinerstr. 5DREIEICH 63303GermanyDEU
- Phone+49 61038010
- Fax+49 6 103801150
- Websitehttps://www.biotest.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AddLife AB | 838.77m | 6.76m | 995.12m | 2.29k | 152.17 | 2.33 | 11.42 | 1.19 | 0.6483 | 0.6483 | 80.41 | 42.38 | 0.7393 | 3.62 | 5.53 | 4,258,149.00 | 0.6112 | 5.31 | 0.9299 | 8.83 | 37.16 | 36.89 | 0.8267 | 5.79 | 0.4778 | 1.48 | 0.5173 | 31.73 | 6.62 | 31.30 | -60.42 | 8.00 | 44.43 | -1.89 |
Polypeptide Group AG | 324.72m | -51.42m | 999.95m | 1.20k | -- | 2.61 | -- | 3.08 | -1.52 | -1.52 | 9.58 | 11.30 | 0.5137 | 2.31 | 5.08 | 264,140.20 | -8.13 | 2.59 | -10.37 | 3.26 | 2.81 | 23.73 | -15.83 | 4.58 | 1.12 | -1.56 | 0.2466 | 15.79 | 14.60 | 12.36 | -762.29 | -- | 25.40 | -- |
EIS czcbs lc Sn v Fnnsl Ytrmlr Sny v Tcr | 186.55m | 78.88m | 1.01bn | 1.12k | 12.83 | 1.01 | 10.72 | 5.43 | 4.00 | 4.00 | 9.46 | 50.85 | 0.1578 | 3.00 | 4.85 | -- | 6.67 | 8.82 | 7.16 | 9.40 | 33.76 | 32.94 | 42.29 | 58.23 | 1.14 | -- | 0.0813 | -- | 86.94 | 56.41 | -8.16 | 62.73 | 141.59 | 31.51 |
FAES Farma SA | 451.17m | 91.90m | 1.07bn | 1.75k | 11.42 | 1.59 | 9.62 | 2.37 | 0.2959 | 0.2959 | 1.45 | 2.13 | 0.6009 | 1.26 | 3.96 | 258,105.30 | 12.21 | 13.07 | 13.91 | 15.20 | 65.86 | 64.10 | 20.32 | 19.79 | 1.86 | -- | 0.0348 | -- | 2.83 | 6.83 | 2.63 | 12.24 | 39.26 | 52.23 |
Vetoquinol SA | 529.27m | 55.56m | 1.18bn | 2.48k | 21.21 | 2.24 | 14.64 | 2.24 | 4.70 | 4.70 | 44.73 | 44.53 | 0.7876 | 2.39 | 5.74 | 213,157.90 | 8.27 | 7.09 | 10.44 | 9.40 | 50.31 | 61.27 | 10.50 | 8.84 | 1.86 | -- | 0.0324 | 16.48 | -1.95 | 7.54 | 15.76 | 8.91 | 5.98 | 12.11 |
BioArctic AB | 52.73m | 19.63m | 1.25bn | 88.00 | 76.57 | 16.67 | 58.74 | 23.62 | 2.58 | 2.58 | 6.97 | 11.85 | 0.6026 | -- | -- | 6,999,943.00 | 22.43 | 2.24 | 24.80 | 2.56 | 91.73 | 86.52 | 37.22 | 9.76 | -- | -- | 0.0047 | 0.00 | 169.83 | -2.91 | 2,150.71 | -9.69 | 11.83 | -- |
Cosmo Pharmaceuticals NV | 96.68m | 1.15m | 1.28bn | 325.00 | 1,027.44 | 2.75 | 82.24 | 13.27 | 0.0696 | 0.0696 | 5.86 | 25.98 | 0.1473 | 3.06 | 2.88 | 290,869.70 | 0.2051 | 0.2437 | 0.249 | 0.267 | 59.33 | 57.28 | 1.39 | 2.10 | 3.80 | 2.73 | 0.0042 | 841.86 | -5.26 | 8.07 | -93.34 | -- | 9.62 | -- |
Fagron NV | 762.99m | 70.55m | 1.30bn | 3.46k | 18.38 | 2.80 | 12.05 | 1.70 | 0.9664 | 0.9664 | 10.45 | 6.35 | 0.7715 | 3.87 | 12.43 | 220,517.60 | 7.18 | 7.63 | 8.76 | 9.77 | 43.59 | 43.49 | 9.31 | 10.23 | 1.27 | 4.45 | 0.4395 | 16.28 | 11.57 | 10.10 | 1.34 | 10.48 | 19.64 | 20.11 |
Bonesupport Holding AB | 50.60m | 20.98m | 1.31bn | 105.00 | 62.34 | 28.17 | 59.77 | 25.80 | 3.72 | 3.72 | 9.04 | 8.24 | 1.11 | 0.7186 | 6.60 | 5,629,305.00 | 46.20 | -9.08 | 58.31 | -11.28 | 91.51 | 90.25 | 41.45 | -11.65 | 2.46 | -- | 0.0311 | -- | 79.76 | 43.65 | 459.44 | -- | 18.39 | -- |
Genus plc | 786.20m | 39.01m | 1.34bn | 3.48k | 34.35 | 1.99 | 14.87 | 1.70 | 0.5053 | 0.5053 | 10.18 | 8.71 | 0.6478 | -- | 6.03 | 193,642.10 | 2.90 | 3.58 | 3.30 | 4.20 | -- | -- | 4.47 | 5.44 | 1.40 | 5.44 | 0.3377 | 60.86 | 16.23 | 7.96 | -18.58 | 26.70 | 9.36 | 4.24 |
Biotest AG | 684.60m | 127.00m | 1.39bn | 2.43k | 12.96 | 3.30 | -- | 2.03 | 3.21 | 3.21 | 17.30 | 12.61 | 0.5238 | 1.13 | 3.84 | 282,192.90 | 9.72 | -0.0693 | 12.10 | -0.079 | 40.94 | 28.43 | 18.55 | -0.1527 | 0.8757 | 3.86 | 0.5803 | -- | 32.65 | 11.33 | 490.89 | -- | -9.36 | -- |
Bavarian Nordic A/S | 946.98m | 197.81m | 1.56bn | 1.38k | 7.65 | 1.12 | 5.73 | 1.65 | 19.46 | 19.46 | 92.83 | 132.47 | 0.5281 | 1.92 | 6.10 | 5,121,349.00 | 11.03 | 1.21 | 13.62 | 1.48 | 65.18 | 53.72 | 20.89 | 4.06 | 1.35 | -- | 0.0139 | 0.00 | 124.14 | 69.78 | 524.66 | -- | 35.76 | -- |
Evotec SE | 781.43m | -83.91m | 1.64bn | 5.06k | -- | 1.46 | -- | 2.10 | -0.4743 | -0.4743 | 4.42 | 6.33 | 0.3466 | 19.97 | 4.85 | 154,401.50 | -3.72 | -0.0064 | -4.53 | -0.0076 | 22.40 | 24.51 | -10.74 | -0.0178 | 1.88 | -1.47 | 0.3586 | 0.00 | 3.99 | 15.79 | 52.23 | -- | 50.62 | -- |
Dermapharm Holding SE | 1.14bn | 62.37m | 1.69bn | 3.50k | 26.98 | 3.13 | 10.20 | 1.48 | 1.16 | 1.16 | 21.09 | 10.01 | 0.6354 | 1.44 | 12.10 | 324,664.30 | 3.39 | 8.68 | 4.10 | 10.06 | 63.34 | 61.94 | 5.33 | 12.31 | 0.7852 | 2.56 | 0.6647 | 54.69 | 10.79 | 14.68 | -53.54 | -3.70 | 9.85 | -- |
Galapagos NV | 287.00m | -3.99m | 1.76bn | 646.00 | -- | 0.6289 | -- | 6.13 | -0.0605 | 3.21 | 4.35 | 42.42 | 0.0631 | 0.2134 | 8.33 | 444,266.30 | -0.0877 | -1.48 | -0.098 | -1.65 | 165.64 | -- | -1.39 | -14.42 | 8.84 | -- | 0.0034 | -- | 3.47 | -2.02 | 94.42 | -- | 7.04 | -- |
Almirall SA | 894.52m | -38.47m | 1.79bn | 1.90k | -- | 1.23 | -- | 2.01 | -0.1757 | -0.1757 | 4.27 | 6.99 | 0.3956 | 1.43 | 8.23 | 469,808.80 | -1.70 | 0.922 | -1.97 | 1.08 | 76.25 | 78.06 | -4.30 | 2.48 | 1.57 | 8.54 | 0.216 | -- | 3.62 | 3.40 | -998.72 | -- | -23.27 | -- |
Data as of Apr 26 2024. Currency figures normalised to Biotest AG's reporting currency: Euro EUR
Holder | Shares | % Held |
---|---|---|
Arvernus Capital AGas of 30 Sep 2023 | 8.93k | 0.05% |
Banor Capital Ltd.as of 30 Nov 2021 | 4.45k | 0.02% |
BANTLEON Invest GmbHas of 30 Nov 2023 | 2.00k | 0.01% |
Norges Bank Investment Managementas of 31 Dec 2023 | 0.00 | 0.00% |
Axxion SA (Luxembourg)as of 31 Mar 2023 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2023 - 28 Mar 2024Source: FactSet Research Systems Inc.